Hepatitis E virus infection results in acute graft failure after liver transplantation: a case report

Authors

  • Xiangyan Liu First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
  • Tian Shen First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
  • Zhuoyi Wang First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
  • Li Zhuang First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
  • Wei Zhang First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
  • Jun Yu First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
  • Jian Wu First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
  • Shusen Zheng First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

DOI:

https://doi.org/10.3855/jidc.3638

Keywords:

hepatitis E virus, graft failure, re-transplantation

Abstract

Hepatitis E virus (HEV) infection in most individuals is known as a self-limiting, acute, icteric hepatitis, but evidence shows HEV is responsible for choric hepatitis and rapid progressed liver cirrhosis in immuno-compromised patients. We present the case of a patient whose diagnosis of acute graft failure was due to a HEV infection 7 years after his first liver transplantation because of Wilson’s disease. The process showed severe jaundice with fatigue, poor appetite and continually rising serum aminopherase. The blood serum was found positive for the anti-HEV IgG antibody but negative for anti-HEV IgM or other infections. Cholangiole cholestasis was detected in graft biopsy. Triple hepato-protective drugs (Transmetil, Polyene Phosphatidylcholine, and Compound Ammonium Glycyrrhetate S) alongside five times Artificial Liver Support System (ALSS) did not improve the patient’s condition, but the total bilirubin level rose to more than 900umol/L. So re-transplantation was performed. Blood testing shows normal liver enzymes and bilirubin with persisting anti-HEV IgG antibody positive at the 3-month follow-up.

Author Biographies

Xiangyan Liu, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Division of Hepatobiliary and Pancreatic Surgery, Department of Liver transplantation

Tian Shen, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Division of Hepatobiliary and Pancreatic Surgery, Department of Liver transplantation

Zhuoyi Wang, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Division of Hepatobiliary and Pancreatic Surgery, Department of Liver transplantation

Li Zhuang, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Division of Hepatobiliary and Pancreatic Surgery, Department of Liver transplantation

Wei Zhang, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Division of Hepatobiliary and Pancreatic Surgery, Department of Liver transplantation

Jun Yu, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Division of Hepatobiliary and Pancreatic Surgery, Department of Liver transplantation

Jian Wu, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Division of Hepatobiliary and Pancreatic Surgery, Department of Liver transplantation

Shusen Zheng, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Division of Hepatobiliary and Pancreatic Surgery, Department of Liver transplantation

Downloads

Published

2014-02-13

How to Cite

1.
Liu X, Shen T, Wang Z, Zhuang L, Zhang W, Yu J, Wu J, Zheng S (2014) Hepatitis E virus infection results in acute graft failure after liver transplantation: a case report. J Infect Dev Ctries 8:245–248. doi: 10.3855/jidc.3638

Issue

Vol. 8 No. 02: February 2014

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC